Related Experiment Videos

Reply to Naudet and Colleagues. Cost-Effectiveness in Health Technology Assessment-A Case in Alcohol Dependence

Philippe Laramée¹, Melissa Bell², Thor-Henrik Brodtkorb³

¹Social and Epidemiological Research Department, Centre for Addiction and Mental Health, 33 Russell St, Toronto, ON M5S 2S1, Canada plaramee@outlook.com.

Alcohol and Alcoholism (Oxford, Oxfordshire)

|June 5, 2016

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Antimicrobial resistance profiling and phenotypic characterization of archived clinical Bacillus paranthracis strains.

Microbiology spectrum·2026

Cost-effectiveness of Nivolumab + Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer in England.

Oncology and therapy·2025

The Acceptance of Overall Survival Extrapolation Methods in Solid Tumor Treatments by Health Technology Assessment Agencies in England, France, and Australia between 2017 and 2022.

Medical decision making : an international journal of the Society for Medical Decision Making·2025

Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review.

Journal of market access & health policy·2024

Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective.

Journal of medical economics·2024

Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo.

Journal of medical economics·2024

See all related articles